Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 12, Status: Authorised
Evidence Dossier: Rivaroxaban Viatris – Health & Science What is established Rivaroxaban Viatris is an anticoagulant medication authorized for use in the European Union since November 12, 2021. It contains the active substance rivaroxaban, a direct factor Xa inhibitor, which interferes with thrombin production and helps prevent blood clot formation. The drug…
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 November 2026
Evidence Dossier: Veterinary Medicinal Products Committee Meeting November 2026 What is established In November 2026, the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) held a meeting to review and adopt opinions on several veterinary medicinal products and related regulatory matters. This committee is responsible for the assessment and approval recommendations…
In Rio, A Celebration of Life
What is Established On October 28, 2025, a police operation took place in Complexo da Penha, a group of favelas in Rio de Janeiro, Brazil. During this raid, 122 people died, including two boys and five police officers, as well as two others prior to the official start of the operation. The…
Civil Society Call for Scrutiny of United States’ Rights Record
Evidence Dossier: Civil Society Appeals for Scrutiny of United States’ Human Rights Record Source: Human Rights Watch News, November 6, 2026 What is established The United States is scheduled for its Universal Periodic Review (UPR) by the United Nations on November 10, 2026. The UPR is a peer review of the human…
A New Chapter for Corporate Accountability in the UK and the Road Ahead
What is established On November 4, 2026, the UK government announced plans to introduce legislation that would regulate corporate conduct regarding human rights impacts within their global supply chains. The proposed law aims to impose robust responsibilities on large companies operating in the UK, obliging them to identify, assess, and address abuses…
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 11, Status: Authorised
Evidence Dossier: Vabysmo (faricimab) – Treatment for Retinal Diseases What is established Vabysmo is a medicine containing the active ingredient faricimab, authorized in the European Union since September 15, 2022, for treatment of certain retinal diseases affecting adults. It targets: Wet age-related macular degeneration (wet AMD) — a condition where abnormal blood…
Influenza virus characteristics, week 40 2025 to week 33 2026, EU/EEA
Influenza Virus Characteristics in the EU/EEA: Summary of Surveillance Data from Week 40 2025 to Week 33 2026 What is established The European Centre for Disease Prevention and Control (ECDC), through a report produced on behalf of the European Respiratory Virus Network (ERVI-Net) and the European Reference Laboratory Network for Human Influenza…
Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
Global Economic Impact of COVID-19 Vaccines in the First Year: Evidence from PLOS Medicine The rapid development and deployment of COVID-19 vaccines were a pivotal part of the global response to the pandemic. A recent study published in PLOS Medicine evaluates the economic return-on-investment (ROI) of COVID-19 vaccination during the initial year…
Nice yellow ball in the sky? Not quite.
What is established The sun is the primary source of light and heat energy for Earth, essential for sustaining life. From our vantage point on Earth, it often appears as a simple yellow ball in the sky. However, modern astrophysics has revealed that the sun is a hot, dynamic star with complex…
Time to bring remote workers back in?
What is established Research in organizational behavior and neuroscience demonstrates that in-person work fosters specific social dynamics—such as serendipitous encounters and enhanced neural synchrony—that can drive creativity, trust, and collaboration. This is sometimes referred to as the “Proximity Effect,” where physical closeness promotes richer communication channels, stronger working relationships, and more effective…